4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane...

Details 4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane... 4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane...

2006-04-04

2006-04-04

Coleman, Brenda (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S221000, C540S556000

Reexamination Certificate

active

07022697

ABSTRACT:
The invention relates to compounds of the Formula I, to pharmaceutical compositions comprising them, and to the method of use thereof in the treatment or prevention of disorders linked to a dysfunction of the nicotinic receptors.

REFERENCES:
patent: 5478939 (1995-12-01), Trybulski et al.
patent: 6407095 (2002-06-01), Lochead et al.
patent: 2003/0114461 (2003-06-01), Galli et al.
patent: 0307140 (1989-03-01), None
patent: WO 00/34279 (2000-06-01), None
patent: WO 01/92259 (2001-12-01), None

Affiliated with

Also associated with

Rating

4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3579853